Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial

BackgroundMultiple sclerosis (MS) is a complex inflammatory disease in which demyelination occurs in the central nervous system affecting approximately 2.5 million people worldwide. Intestinal microbiome changes play an important role in the etiology of chronic diseases.ObjectiveThis study aimed to...

Full description

Bibliographic Details

Published in:	Frontiers in Neuroscience
Main Authors:	Mehran Rahimlou, Shima Nematollahi, Durdana Husain, Nasrin Banaei-Jahromi, Nastaran Majdinasab, Seyed Ahmad Hosseini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Subjects:	probiotic multiple sclerosis inflammation clinical trial gut microbiome
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2022.901846/full